Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a blood test tell which lung cancer patients can skip chemo? Results expected Dec 2026 (estimated)
- Smart blood tests may personalize lung cancer care after targeted therapy Results expected Dec 2026 (estimated)
- Single-Drug immunotherapy shows promise for advanced lung cancer Results expected May 2027 (estimated)
- New hope for KRAS-driven lung cancer: drug duo targets tough mutation Results expected Sep 2027 (estimated)
-
Can a drug duo outsmart ALK-Positive lung cancer?
Disease control Not yet recruitingThis trial is testing whether combining two targeted therapies—lorlatinib and sacituzumab tirumotecan—can better control advanced ALK-positive non-small cell lung cancer when used as the first treatment. The study involves about 153 adults with locally advanced or metastatic dise…
Phase 2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New cocktail therapy aims to tackle Drug-Resistant lung cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether a combination of the experimental drug QL1706, standard chemotherapy, and bevacizumab can shrink tumors in people with advanced non-squamous non-small cell lung cancer that has specific gene changes and has stopped responding to targeted ther…
Phase 2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Real-World data to reveal IBI351's impact on tough lung cancer
Disease control Not yet recruitingThis study looks back at medical records of 600 Chinese patients with advanced non-small cell lung cancer that has a KRAS G12C mutation. All patients took the drug IBI351 between August 2024 and August 2025. Researchers will check how many patients' tumors shrank or disappeared, …
Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC